Friday, 25 October 2013

FDA Panel Backs HCV Drugs

(MedPage Today) -- An FDA advisory committee has unanimously supported approval of both simeprevir and sofosbuvir, drugs that act directly against hepatitis C (HCV). via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)